2021
DOI: 10.1101/2021.04.03.438258
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies

Abstract: Investigating the mechanisms of SARS-CoV-2 cellular infection is key to better understand COVID-19 immunity and pathogenesis. Infection, which involves both cell attachment and membrane fusion, relies on the ACE2 receptor that is paradoxically found at low levels in the respiratory tract, suggesting that additional mechanisms facilitating infection may exist. Here we show that C-type lectin receptors, DC-SIGN, L-SIGN and the sialic acid-binding Ig-like lectin 1 (SIGLEC1) function as auxiliary receptors by enha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
39
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 34 publications
(43 citation statements)
references
References 65 publications
4
39
0
Order By: Relevance
“…6e). Like other non-ACE2-competitive antibodies 31,32 , S2H97 neutralization is attenuated in cells that over-express ACE2 (Extended Data Fig. 6f).…”
Section: The Pan-sarbecovirus S2h97 Antibodymentioning
confidence: 85%
See 3 more Smart Citations
“…6e). Like other non-ACE2-competitive antibodies 31,32 , S2H97 neutralization is attenuated in cells that over-express ACE2 (Extended Data Fig. 6f).…”
Section: The Pan-sarbecovirus S2h97 Antibodymentioning
confidence: 85%
“…6b), even more than is required to access the cryptic antigenic site II 15 . Like other antibodies that only bind the open RBD 30,31 , S2H97 induces rapid and premature refolding of spike into the post-fusion state (Fig. 2e), promotes S1 shedding of cell-surface-expressed spike (Extended Data Fig.…”
Section: The Pan-sarbecovirus S2h97 Antibodymentioning
confidence: 99%
See 2 more Smart Citations
“…Assays for neutralizing antibodies elicited by the spike protein, have been the primary measure of COVID-19 vaccine immunity. Most neutralization assays are variable across assay systems and cell lines 50,51 , which limits their use to define a correlate that spans clinical studies of different vaccines, and they do not distinguish between responses to different epitopes on the spike protein, some of which are highly immunodominant 52 . The establishment of a WHO international standard to allow normalization of data from different assays is an important step towards addressing this issue (www.who.int/teams/blueprint/covid-19).…”
Section: The Role Of Vaccines and The Identification Of Correlates Of Protectionmentioning
confidence: 99%